• Pfizer Agrees to Pay $345 Mln to Resolve EpiPen Pricing Lawsuit

    2 monthes ago - By Medscape

    Pfizer Inc has agreed to pay $345 million to resolve claims by consumers who say they overpaid for EpiPens due to anticompetitive practices by the drugmaker and the company that markets the emergency allergy treatment, Mylan.
    Reuters Health Information
    Read more ...